Neuroeffector mechanisms: The interface between inflammation and neuronal responses

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 5 SUPPL., 1996, Pages

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Adrenergic nervous system; Asthma; Cholinergic pathways; Neurogenic inflammation; Nonadrenergic noncholinergic pathways; Sensory nerves; Symptoms

Indexed keywords

ADRENERGIC SYSTEM; ASTHMA; CHOLINERGIC NERVE; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY NERVE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BRONCHI; BRONCHIAL HYPERREACTIVITY; HUMANS; INFLAMMATION MEDIATORS; NEUROTRANSMITTER AGENTS;

EID: 0029949572     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70020-9     Document Type: Article

References (67)

1. Barnes PJ. Neural control of human airways in health and disease. Am Rev Respir Dis 1986;134:1289-314.
2. Barnes PJ. Neural control of human airway function: new perspectives. Molec Aspects Med 1990;11:351-423.
3. Barnes PJ, Baraniuk J, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991;144:1187-98, 1391-9.
4. Coleridge HM, Coleridge JCG. Afferent nerves in the airways. In: Barnes PJ, editor. Autonoic control of the respiratory system. London: Harwood. In press.
5. Fox AJ, Barnes PJ, Urban L, Dray A. An in vitro study of the properties of single vagal afferents innerrating guineapig airways. J Physiol 1993;469:21-35.
6. Fox AJ, Barnes PJ, Dray A. Stimulation of afferent fibres in the guinea-pig trachea by non-isosmotic and low chloride solutions and its modulation by furosemide. J Physiol 1995;482:179-87.
7. Fox AJ, Dray A, Barnes PJ. The activity of prostaglandins and platelet-activating factor on single airway sensory fibres of the guinea-pig in vitro [abstract]. Am J Respir Crit Care Med 1995;151:A110.
8. Fox AJ, Urban L, Barnes PJ, Dray A. Effects of capsazcpine against capsaicin and proton-evoked excitation of single airway C-fibres and vagus nerve from the guinea-pig. Neuroscience 1995;67:741-52.
9. Widdicombe JG, Karlsson J-A, Barnes PJ. Cholinergic mechanisms in bronchial hyperresponsiveness and asthma. In: Kaliner MA, Barnes PJ, Persson CGA, editors. Asthma: its pathology and treatment. New York: Marcel Dekker, 1991:327-56.
10. Molfino NA, Slutsky AS, Julia-Serda G, et al. Assessment of airway tone in asthma. Am Rev Respir Dis 1993;148:1238-43.
11. Barnes PJ. Modulation of neurotransmission in airways. Physiol Rev 1992;72:699-729.
12. Undem B J, Myers AC, Weinreich D. Antigen-induced modulation of autonomie and sensory neurons in vitro. Int Arch Allergy Appl Immunol 1991;94:319-24.
13. Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci 1993;52:521-8.
14. Mak JCW, Barnes PJ. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 1990;141:1559-68.
15. Mak JCW, Baraniuk JN, Barnes PJ. Localization of muscarinic receptor subtype mRNAs in human lung. Am J Respir Cell Mol Biol 1992;7:344-8.
16. Patel HJ, Barnes PJ, Takahashi T, Tadjkarimi S, Yaeoub MH, Belvisi MG. Characterization of prejunctional muscarinic autoreceptors in human and guinea-pig trachea in vitro. Am J Respir Crit Care Med 1995;152;838-60.
17. Minette PAH, Lammers J, Dixon CMS, McCusker MT, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 1989;67:2461-5.
18. Ind PW, Dixon CMS, Fuller RW, Barnes PJ. Anticholinergic blockade of betablocker induced bronchoconstriction. Am Rev Respir Dis 1989;139:1390-4.
19. Okayama M, Shen T, Midorikawa J, Lin J-T, Inoue H, Takishima T, et al. Effect of pilocarpine on propranolol-induced bronchoconstriction in asthma. Am J Resp Crit Care Med 1994;149:76-80.
20. 2 receptor. J Clin Invest 1993;91: 1314-8.
21. 1) muscarinic receptors in vagally mediated bronchoconstriction in humans. Am Rev Respir Dis 1989;139:446-9.
22. Barnes PJ. Endogenous catecholamines and asthma. J Allergy Clin Immunol 1986;77:791-5.
23. Spina D, Rigby PJ, Paterson JW, Goldie RG. α-Adrenoceptor function and autcradiographic distribution in human asthmatic lung. Br J Pharmacol 1989;97:701-8.
24. 2-adrenocepter messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur J Pharmacol 1991;206:133-8.
25. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, β-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 1986;22:669-76.
26. Bai TR. Abnormalities in airway smooth muscle in fatal asthma: a comparison between trachea and bronchus. Am Rev Respir Dis 1991;143:441-3.
27. Bai TR, Mak JCW, Barnes PJ. A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 1992;6:647-51.
28. Grandordy BM, Mak JCW, Barnes PJ. Modulation of airway smooth muscle adrenoceptor function by a muscarinic agonist. Life Sci 1994;54:185-91.
29. Lammers JWJ, Barnes PJ, Chung KF. Non-adrenergic, non-cholincrgic airway inhibitory nerves. Eur Respir J 1992;5:239-46.
30. Miura M, Ichinose M, Kimura K, Katsumata U, Takahashi T, Inoue H, et al. Dysfunction of nonadrenergic noncholinergic inhibitory system after antigen inhalation in actively sensitized cat airways. Am Rev Respir Dis 1992;145:70-4.
31. Lammers J-WJ, Minette P, McCusker M, Chung KF, Barnes PJ. Capsaicin-induced bronchodilatation in mild asthmatic subjects: possible role of nonadrenergic inhibitory system. J Appl Physiol 1989;67:856-61.
32. Belvisi MG, Ward JK, Tadjarimi S, Yacoub MH, Barnes PJ. Inhibitory NANC nerves in human airways: differences in disease and after extrinsic denervation [abstract]. Am Rev Respir Dis 1993;147:A286.
33. Li CG, Rand MJ. Evidence that part of the NANC relaxant response of guineapig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 1991;102:91-4.
34. Belvisi MG, Miura M, Stretton CD, Barnes PJ. Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea-pig trachea. Eur J Pharmacol 1993;231:97-102.
35. Ollerenshaw S, Jarvis D, Woolcook A, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989;320:1244-8.
36. Belvisi MG, Stretton CD, Miura M, Verleden GM, Tadjadmi S, Yacoub MH, et al. Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. J Appl Physiol 1992;73:2505-10.
37. Ward JK, Belvisi MG, Fox AJ, Miura M, Tadjkarimi S, Yacoub MH, et al. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 1993;92: 736-43.
38. Belvisi MG, Stretton CD, Barnes PJ. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea pig airways. Eur J Pharmacol 1991;198:219-21.
39. Belvisi MG, Stretton CD, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 1992;210:221-2.
40. Daniele RP, Barnes PJ, Goetzl EJ, Nadel J, O'Dorisio S, Kiley J, et al. Neuroimmune interactions in the lung. Am Rev Respir Dis 1992;145:1230-5.
41. Kuo H-P, Rhode JAL, Tokuyama K, Barnes PJ, Rogers DF. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea-pig trachea. J Physiol 1990; 431:629-41.
42. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea-pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 1989;248:292-8.
43. Nadel JA. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991;4:745-54.
44. Tsugoshi H, Haddad E-B, Sun J, Barnes PJ, Chung KF. Ozone-induced airway hyperresponsiveness: role of superoxide anions, NEP, and BK receptors. J Appl Physiol 1995;78:1015-22.
45. Tsukagoshi H, Sun J, Kwon O, Barnes PJ, Chung KF. Role of neutral endopeptidase in bronchial hyperresponsiveness to bradykinin induced by IL-1β. J Appl Physiol 1995;78: 921-7.
46. Widdicombe JG. The NANC system and airway vasculature. Arch Int Phamacodyn 1990;303:83-90.
47. Mak JCW, Barnes PJ. Autoradiographic localization of calcitonin gene-related peptide binding sites in human and guinea-pig lung. Peptides 1988;9:957-64,
48. Matsuse T, Thomson RJ, Chen X-R, Salari H, Schellenberg RR. Capsaicin inhibits airway hyperresponsiveness, but not airway lipoxygenase activity nor eosinophilia following repeated aerosolized antigen in guinea-pigs. Am Rev Respir Dis 1991;144:368-72.
49. Lötvall JO, Hui KP, Löfdahl C-G, Barnes PJ, Chung KF. Capsaicin pretreatment does not inhibit allergen-induced airway microvascular leakage in guinea-pig. Allergy 1991; 46:105-8.
50. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and non-asthmatics. Eur Respir J 1991;4:673-82.
51. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and non-asthmatic patients. Am J Respir Crit Care Med 1995;151: 548-53.
52. Niebcr K, Baumgarten CR, Rathsack R, Furked J, Ochame P, Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without asthma. J Allergy Clin Immunol 1992;90:646-52.
53. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995;151:613-7.
54. Barnes PJ. Bradykinin and asthma. Thorax 1992;47:979-83.
55. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by a neurokinin receptor antagonist. Lancet 1992;340:1248-51.
56. Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 1993;11:1-7.
57. Cheung D, Bel EH, den Hartigh J, Dijkman JH, Sterk PJ. An effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis 1992;145:1275-80.
58. Baraniuk JN, Mak J, Letarte M, Davis R, Twort C, Barnes PJ. Neutral endopeptidase mRNA expression in airways [abstract]. Am Rev Respir Dis 1991;143:A40.
59. Nichol GM, O'Connor B, Chung KF, Barnes PJ. Effect of a neutral endopeptidase inhibitor on airway function in asthmatic subjects [abstract]. Am Rev Respir Dis 1990;141: A663.
60. Barnes PJ. Neuropeptides and asthma. In: Kaliner MA, Barnes PJ, Kunkel GHH, Baraniuk JN, editors. Neuropeptides in respiratory medicine, New York: Marcel Dekker, 1994:285-311.
61. Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory diseases. Trends Pharmacol Sci 1990;11:185-9.
62. 1-receptor antagonist. Br J Pharmacol 1992;105:261-2.
63. 1-receptor antagonist against substance P-, bradykinin-, and allergen-induced airway microvascular leak and bronchoconstriction in the guinea-pig. Eur J Pharmacol 1993;231:31-8.
64. Stretton CD, Miura M, Belvisi MG, Barnes PJ. Caldum-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proc Natl Acad Sci USA 1992;89:1325-9.
65. Verleden GM, Belvisi MG, Stretton CD, Barnes PJ. Nedocromil sodium modulates non-adrenergic non-cholinergic bronchoconstrietor nerves in guineapig airways in vitro. Am Rev Respir Dis 1991;143:114-8.
66. Dixon CMS, Barnes PJ. Bradykinin induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmaeol 1989;27:831-6.
67. Barnes PJ. Diuretics and asthma. Thorax 1993;48:195-7.